ultimate (paziņots 2009.) tablete
rbc life sciences, inc. - tablete
ultimate max (2021.) kapsula
kapsula
ultimate w+ (2016.) cits, šķīdums
laboratorios exiko s.l. - cits, Šķīdums
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomīds - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
klertis 12,5 mg cietās kapsulas
egis pharmaceuticals plc, hungary - sunitinibs - kapsula, cietā - 12,5 mg
klertis 25 mg cietās kapsulas
egis pharmaceuticals plc, hungary - sunitinibs - kapsula, cietā - 25 mg